Oxford BioDynamics (LON:OBD) Trading Up 9% – Still a Buy?

Oxford BioDynamics Plc (LON:OBD) shares shot up 9% during trading on Wednesday . The company traded as high as GBX 1.20 ($0.01) and last traded at GBX 1.03 ($0.01). 1,819,385 shares were traded during trading, a decline of 3% from the average session volume of 1,876,246 shares. The stock had previously closed at GBX 0.94 ($0.01).

Oxford BioDynamics Price Performance

The company has a fifty day moving average price of GBX 1.31 and a two-hundred day moving average price of GBX 4.60. The firm has a market capitalization of £4.04 million, a PE ratio of -21.58 and a beta of 0.42. The company has a current ratio of 0.68, a quick ratio of 2.80 and a debt-to-equity ratio of 370.22.

Insider Activity

In other Oxford BioDynamics news, insider David Holbrook acquired 49,653 shares of the company’s stock in a transaction on Monday, October 28th. The shares were bought at an average cost of GBX 1 ($0.01) per share, for a total transaction of £496.53 ($620.58). Corporate insiders own 16.78% of the company’s stock.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.